All Outputs (5)

Shared decision-making and patient decision aids in dermatology (2016)
Journal Article
Tan, J., Linos, E., Sendelweck, M. A., van Zuuren, E. J., Ersser, S., Dellavalle, R. P., & Williams, H. C. (in press). Shared decision-making and patient decision aids in dermatology. British Journal of Dermatology, 175(5), https://doi.org/10.1111/bjd.14803

Shared decision making combines individual patient interests and values with clinical best evidence under the guiding principle of patient autonomy. Patient decision aids can support shared decision making and facilitate decisions that have multiple... Read More about Shared decision-making and patient decision aids in dermatology.

What is the evidence-base for atopic eczema treatments? A summary of published randomised controlled trials (2016)
Journal Article
Nankervis, H., Thomas, K., Delamere, F. M., Barbarot, S., Smith, S., Rogers, N. K., & Williams, H. C. (in press). What is the evidence-base for atopic eczema treatments? A summary of published randomised controlled trials. British Journal of Dermatology, 176(4), https://doi.org/10.1111/bjd.14999

Atopic eczema (AE) is a common chronic inflammatory skin condition. Whilst many AE treatment options are available, the evidence to support their efficacy varies in depth and quality. In 2000, an NIHR HTA systematic review identified and evaluated ex... Read More about What is the evidence-base for atopic eczema treatments? A summary of published randomised controlled trials.

Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study (2016)
Journal Article
Thomas, K. S., Ormerod, A. D., Craig, F. E., Greenlaw, N., Norrie, J., Mitchell, E., …Williams, H. C. (2016). Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study. Journal of The American Academy of Dermatology, 75(5), 940-949. https://doi.org/10.1016/j.jaad.2016.06.016

Background: pyoderma gangrenosum (PG) is an uncommon dermatosis with a limited evidence base for treatment. Objective: to estimate the effectiveness of topical therapies in the treatment of PG. Methods: prospective cohort study of UK secondary... Read More about Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study.

Scoping systematic review of treatments for eczema (2016)
Journal Article
Nankervis, H., Thomas, K., Delamere, F. M., Barbarot, S., Rogers, N. K., & Williams, H. C. (2016). Scoping systematic review of treatments for eczema. Programme Grants for Applied Research, 4(7), https://doi.org/10.3310/pgfar04070

Background: Eczema is a very common chronic inflammatory skin condition. Objectives: To update the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) systematic review of treatments for atopic eczema, published in 2000,... Read More about Scoping systematic review of treatments for eczema.

Specific allergen immunotherapy for the treatment of atopic eczema (2016)
Journal Article
Tam, H., Calderon, M. A., Manikam, L., Nankervis, H., Núñez, I. G., Williams, H. C., & Boyle, R. (2016). Specific allergen immunotherapy for the treatment of atopic eczema. Cochrane Database of Systematic Reviews, Article CD008774. https://doi.org/10.1002/14651858.CD008774.pub2

BACKGROUND: Specific allergen immunotherapy (SIT) is a treatment that may improve disease severity in people with atopic eczema (AE) by inducing immune tolerance to the relevant allergen. A high quality systematic review has not previously assess... Read More about Specific allergen immunotherapy for the treatment of atopic eczema.